BDBM300626 3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amino}-N-[6-(2- fluorophenyl)pyridin-3-yl]-4- (trifluoromethoxy)benzamide::US10130633, Example 196

SMILES CC(C(=O)Nc3cc(C(=O)Nc2ccc(c1ccccc1F)nc2)ccc3OC(F)(F)F)N5CCN(C4CC4)CC5

InChI Key InChIKey=CKDUXLHDEQCHIL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 300626   

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300626(3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amin...)
Affinity DataIC50: 143nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
Go to US Patent

TargetProtein Wnt-3a(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM300626(3-{[2-(4-cyclopropylpiperazin-1- yl)propanoyl]amin...)
Affinity DataIC50: 5.00E+4nMAssay Description:In preparation of the assay, the two cell lines were plated 24 hours before at 10000 cells per well of a 384 micro titre plate (MTP) in 30 μL gr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2019
Entry Details
Go to US Patent